Every November, the diabetes community comes together to recognize both National Diabetes Month in the U.S. and World Diabetes Day. World Diabetes Day falls on today, Nov. 14, to mark the birthday of Sir Frederick Banting. Banting discovered the insulin hormone along with Charles Herbert Best in 1922. In an effort to drive awareness and […]
Insulet
Insulet stock soars on Q3 results, Dexcom G7 integration planned for early 2024
Insulet (Nasdaq:PODD) shares got a boost from third-quarter results that came in ahead of the consensus forecast. Shares of PODD were up more than 16% at $162.94 near the end of trading today — a day after the company released results after market close. MassDevice’s MedTech 100 Index — which includes stocks of the world’s […]
Insulet launches National Diabetes Month initiatives
Insulet (Nasdaq:PODD) today announced a series of initiatives to recognize National Diabetes Awareness Month and World Diabetes Day. The U.S. recognizes the month of November as National Diabetes Awareness Month, while World Diabetes Day falls on Nov. 14. To recognize World Diabetes Day, Insulet’s team will appear at the Nasdaq Stock Market for the ninth […]
FDA clears iPhone app for the Insulet Omnipod 5
Insulet (Nasdaq:PODD) announced today that the FDA granted 510(k) clearance for its Omnipod 5 App for iPhone. Clearance makes Insulet the only company offering a tubeless, automated insulin delivery (AID) system with full control from a compatible Android and iOS smartphone. The company first launched the system, compatible with Android devices, in August 2022. Insulet […]
The challenges Insulet overcame to deliver the Omnipod 5 automated insulin delivery system
Insulet (Nasdaq:PODD) had to clear a series of hurdles to bring the Omnipod 5 automated insulin delivery system to those who need it. Speaking at DeviceTalks West in Santa Clara, California on Oct. 18, Mark Field, Insulet’s CTO, explained the trials and tribulations. He presented in a session titled “Overcoming Challenges to Develop the Omnipod […]
Insulet CFO departs for same post at 3M’s Health Care spinoff
Insulet (Nasdaq:PODD) announced today that Wayde McMillan decided to leave his role as EVP, CFO and treasurer. McMillan’s departure goes into effect on Oct. 20, 2023. He intends to join 3M as CFO of its Health Care business, which the company expects to spin off late this year or early next year. President and CEO […]
Analysts: GLP-1 drugs should have minor impact on insulin pump market — but will boost CGMs
Based on conversations with diabetes experts, analysts are playing down the potentially negative impact of GLP-1 receptor agonists on the diabetes technology industry. The GLP-1 drug class, which includes Ozempic and Wegovy, has cast a shadow of doubt over diabetes technology of late. This therapeutic class, a glucagon-like peptide 1, has proven to lead to […]
Insulet fully launches Omnipod 5 in Germany, expects full European availability by end of 2024
Insulet (Nasdaq:PODD) announced today that it commercially launched its Omnipod 5 automated insulin delivery system in Germany. Acton, Massachusetts-based Insulet released the device for individuals aged two years and older with type 1 diabetes. Germany marks the third market for the latest-generation patch pump. The company launched Omnipod 5 in the U.S. in August 2022, […]
Insulet raises 2023 guidance with Omnipod sales up 33%
Insulet (Nasdaq:PODD) stock is down today, even with Street-beating Q2 results and raised guidance. Shares of PODD were down more than 3% at $229.85 apiece by midday trading today. (Insulet announced its earnings yesterday evening.) MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was down slightly. The […]
Report: Insulet prevails over Medtrum in France patent spat
According to a report in Europe, a Paris court found that Medtrum’s latest insulin pumps infringe an Insulet (Nasdaq:PODD) patent. JUVE Patent reported that earlier this month, the Judicial Court of Paris declared the infringement. The court found that Medtrum’s newest pump base and patch reservoir models violate the EP2438957B1 patent from Insulet. In declaring […]